α-interferon in hematological malignancies

Frank J. Giles*, Howard Ozer

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Abstract

Recent studies have generated data demonstrating significant clinical activity of α-interferon therapy in each of six hematological malignancies, chronic myeloid leukaemia, essential thrombocythemia, polycythemia rubra vera, non-Hodgkin's lymphomas, multiple myelomatosis and hairy cell leukaemia.

Original languageEnglish (US)
Pages (from-to)847-850
Number of pages4
JournalCurrent Opinion in Biotechnology
Volume2
Issue number6
DOIs
StatePublished - Dec 1991

ASJC Scopus subject areas

  • Biotechnology
  • Bioengineering
  • Biomedical Engineering

Fingerprint Dive into the research topics of 'α-interferon in hematological malignancies'. Together they form a unique fingerprint.

Cite this